Market Cap : 465.34 M | Enterprise Value : 939.56 M | PE Ratio : At Loss | PB Ratio : 0.61 |
---|
NAS:ZIMV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ZIMV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ZimVie's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $26.6 Mil. ZimVie's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $577.7 Mil. ZimVie's Total Stockholders Equity for the quarter that ended in Jun. 2022 was $764.6 Mil. ZimVie's debt to equity for the quarter that ended in Jun. 2022 was 0.79.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for ZimVie's Debt-to-Equity or its related term are showing as below:
During the past 4 years, the highest Debt-to-Equity Ratio of ZimVie was 0.79. The lowest was 0.04. And the median was 0.06.
The historical data trend for ZimVie's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ZimVie's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where ZimVie's Debt-to-Equity falls into.
Debt to Equity measures the financial leverage a company has.
ZimVie's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (12.6 | + | 45.3) | / | 1451.4 | |
= | 0.04 |
ZimVie's Debt to Equity Ratio for the quarter that ended in Jun. 2022 is calculated as
Debt to Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (26.602 | + | 577.67) | / | 764.557 | |
= | 0.79 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Thank you for viewing the detailed overview of ZimVie's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Crawford Sally | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Kuntz Richard | director | MEDTRONIC, INC. 710 MEDTRONIC PWKY MS LC 310 MINNEAPOLIS MN 55432 |
Asar Vinit K | director | 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 |
Matusinec Karen | director | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
King David P | director | PRIVIA HEALTH GROUP, INC. 950 N. GLEBE RD., SUITE 700 ARLINGTON VA 22203 |
Zimmer Biomet Holdings, Inc. | 10 percent owner | 345 EAST MAIN STREET WARSAW IN 46580 |
Whitney Rebecca Ann | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Harmon David John | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Jamali Vafa | director, officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kanaglekar Indraneel | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kidwell Heather | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Schneider Sandra | officer: Chief Accounting Officer | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Heppenstall Richard | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
From GuruFocus
Other Sources